anymedi Inc.
Uses AI analysis of medical imaging to 3D-print patient-specific surgical guides, implants, and simulators.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2016 and listed on KONEX in 2022, anymedi specializes in medical-imaging-based, patient-specific surgical solutions. It analyzes patients' CT/MRI images with AI to 3D-print implants, surgical guides, and simulators, and sells the cosmetic implant brand Innofit along with its medical AI product line. Its congenital heart disease simulator, shoulder replacement surgical guide, and mandible reconstruction surgical guide were registered as new health technologies, while its partial mastectomy surgical guide and orbital fracture implant guide were registered as innovative health technologies; revenue was about KRW 650 million in 2022, KRW 1.12 billion in 2023, KRW 1.36 billion in 2024 (up 20% YoY), and KRW 1.83 billion in 2025 (up 35% YoY).
Products & technology
- InnofitCosmetic implant
- Congenital heart disease simulator3D-printed organ model for surgical planning and simulation
- Shoulder replacement surgical guidePrecision surgical incision guidance
- Mandible reconstruction surgical guideSurgical guide for mandible reconstruction
- Partial mastectomy surgical guideImproves tumor removal rate and minimizes surgical area
- Orbital fracture implant guideSurgical guide for orbital fracture implant
Regulatory approvals
data.go.kr24 Korean MFDS device approvals · 2017–2026
- MFDSGuide for medical use, invasive, single use2026-07-21Product approval · Class 2제인 26-4668 호
- MFDSGuide for medical use2026-05-11Product approval · Class 1제신 26-587 호
- MFDSCranioplasty plate2025-07-25Product approval · Class 3제허 25-509 호
- MFDSGuide for medical use2025-03-18Product approval · Class 1제신 25-330 호
- MFDSGuide for medical use, invasive, single use2023-03-21Product approval · Class 2제인 23-4568 호
- MFDSGuide for medical use, invasive, single useRevoked2022-05-02Product approval · Class 2제인 22-4350 호
- MFDSCranioplasty plateRevoked2021-08-11Product approval · Class 3제허 21-682 호
- MFDSGuide for medical use, invasive, single use2021-08-05Product approval · Class 2제인 21-4670 호
- MFDSGuide for medical use, invasive, single useRevoked2021-07-29Product approval · Class 2제인 21-4648 호
- MFDSNasal splint, external2020-09-15Product approval · Class 1제신 20-1416 호
- MFDSGuide for medical use2020-04-16Product approval · Class 1제신 20-525 호
- MFDSTissue reconstructive material, synthetic, silicone, block2020-02-13Product approval · Class 3제허 20-114 호
Show 12 more
- MFDSGuide for medical use2019-12-04Product approval · Class 1제신 19-1583 호
- MFDSGuide for medical use2019-11-22Product approval · Class 1제신 19-1531 호
- MFDSTissue reconstructive material, synthetic, silicon, non-implantable2019-03-07Product approval · Class 1제신 19-291 호
- MFDSGuide for medical useRevoked2018-03-23Product approval · Class 1제신 18-350 호
- MFDSGuide for medical useRevoked2018-03-14Product approval · Class 1제신 18-307 호
- MFDSSizer for medical or dental useRevoked2018-03-12Product approval · Class 1제신 18-289 호
- MFDSSizer for medical or dental useRevoked2018-03-12Product approval · Class 1제신 18-286 호
- MFDSGuide for medical useRevoked2018-03-09Product approval · Class 1제신 18-282 호
- MFDSGuide for medical useRevoked2017-10-10Product approval · Class 1제신 17-1151 호
- MFDSGuide for medical useRevoked2017-02-03Product approval · Class 1제신 17-123 호
- MFDSGuide for medical use2017-02-03Product approval · Class 1제신 17-120 호
- MFDSGuide for medical useRevoked2017-02-03Product approval · Class 1제신 17-118 호
R&D and key agreements
Source: DART corporate disclosure맞춤형 수술 AI 플랫폼 · Built on three core technologies: AI-based personalized surgical design from medical imaging, surgical plan implementation, and virtual surgery/platform technology
Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Manufactures spinal implants and metal 3D-printed patient-specific implants, exporting to over 25 countries.
Founded in 2000 and KOSDAQ-listed in 2013, Corentec makes artificial joints; hip and knee implants exceed 85% of revenue.
Established in 2012 and listed on KOSDAQ in 2018, Osteonic manufactures implants for the CMF, Trauma, Sports Medicine, and Spine categories.
Founded in 1997 and KOSDAQ-listed in 2015, CG MedTech makes orthopedic medical devices and also operates an electric energy business.
Alpha AI, founded in 1995 and KOSDAQ-listed in 2000, manufactures biocompatible metal implants and surgical instruments.
Spinal implant device maker founded 2008, listed on KOSDAQ 2016; produces Cervical and Thoraco Lumbar Cage, Screw, and Plate products.
KOSDAQ-listed holding company making medical devices and biologics including bone graft rhBMP2 and knee implant TKR.
Founded in 1982 and KOSDAQ-listed in 2008, Sewoon Medical manufactures medical aspirators and catheters/tubes.
Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.
Organ Eco Tech, founded in 2006 and KONEX-listed in 2016, manufactures spinal implants.
Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.
Founded in 2014 and listed on KONEX in 2020, RootLoc manufactures artificial knee joints and spinal implants for orthopedic surgery.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition